By vgreene, 11 September, 2015 LAIV not recommended due to limited data; LAIV contraindicated in pts >49 yo
By vgreene, 11 September, 2015 IIV<sup>44,45</sup> may be used (if RIV3 unavailable), but should be given by a clinician familiar w/ recognition and mgmt of severe allergic conditions, and recipients observed for ≥30 min<sup>46</sup>
By vgreene, 11 September, 2015 If hx of severe rxn,<sup>40</sup> vaccinate annually<sup>41</sup> w/ trivalent recombinant influenza vaccine (RIV3)<sup>42,43</sup> unless unavailable
By vgreene, 11 September, 2015 Trivalent recombinant influenza (RIV3) not licensed for use in pts <18 yo
By vgreene, 11 September, 2015 If hx of severe rxn,<sup>35</sup> vaccinate annually<sup>36</sup> w/ IIV<sup>37,38</sup> given by a clinician familiar w/ recognition and mgmt of severe allergic conditions, and recipients observed for ≥30 min<sup>39</sup>